Tag Archives: ONCS

OncoSec Medical (ONCS) Receives a Buy from Maxim Group

In a report released yesterday, Jason McCarthy from Maxim Group assigned a Buy rating to OncoSec Medical (ONCS – Research Report), with a price target of $5.00. The company’s shares closed last Tuesday at $4.09. According to TipRanks.com, McCarthy is

Ladenburg Thalmann & Co. initiated Buy on OncoSec Medical Shares, Sees 100% Upside For The Stock

In a research report sent to investors on Monday, Ladenburg Thalmann & Co. analyst Robert LeBoyer initiated Buy rating on OncoSec Medical (NASDAQ:ONCS)with a price target of $8, which implies an upside of 100% from current levels. According to TipRanks.com,

Thursday’s Midday Stock Update: American Green Inc (ERBB), Acura Pharmaceuticals Inc (ACUR), NovaBay Pharma (NBY), Anthera Pharmaceuticals (ANTH), OncoSec Medical (ONCS)

So far Thursday, July 18, NASDAQ is up 0.17% and the S&P is up 0.53%. Here are this morning’s most active stocks: American Green Inc (ERBB – Research Report), Acura Pharmaceuticals Inc (ACUR – Research Report), NovaBay Pharma (NBY –

Friday’s Midday Stock Update: American Green Inc (ERBB), OHR Pharmaceutical (OHRP), Karyopharm Therapeutics (KPTI), Dynavax (DVAX), OncoSec Medical (ONCS)

So far Friday, July 5, NASDAQ is up 0.96% and the S&P is up 0.32%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; American Green Inc (ERBB – Research Report), OHR Pharmaceutical (OHRP

Analysts’ Top Services Picks: OncoSec Medical (ONCS), Pareteum Corp (TEUM)

There’s a lot to be optimistic about in the Services sector as 2 analysts just weighed in on OncoSec Medical (ONCS – Research Report) and Pareteum Corp (TEUM – Research Report) with bullish sentiments. OncoSec Medical (ONCS) Maxim Group analyst

Thursday’s Highlights at Noon: NovaBay Pharma (NBY), Kandi Technologies (KNDI), AVEO Pharma (AVEO), Agios Pharma (AGIO), OncoSec Medical (ONCS)

So far Thursday, May 16, NASDAQ is up 4.23% and the S&P is up 2.81%. Here are this morning’s most active stocks: NovaBay Pharma (NBY – Research Report), Kandi Technologies (KNDI – Research Report), AVEO Pharma (AVEO – Research Report),